Fidelity Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-70,017
Closed -$17.2M 5664
2022
Q3
$17.2M Buy
70,017
+2,300
+3% +$621K ﹤0.01% 1660
2022
Q2
$16.8M Buy
67,717
+31,522
+87% +$8.51M ﹤0.01% 1720
2022
Q1
$12M Buy
36,195
+34,768
+2,436% +$10.7M ﹤0.01% 2039
2021
Q4
$513K Buy
1,427
+130
+10% +$43.9K ﹤0.01% 2793
2021
Q3
$422K Buy
1,297
+293
+29% +$99.3K ﹤0.01% 2830
2021
Q2
$313K Sell
1,004
-2,352
-70% -$722K ﹤0.01% 2859
2021
Q1
$1.07M Buy
3,356
+3,209
+2,183% +$1.03M ﹤0.01% 2571
2020
Q4
$48K Buy
147
+83
+130% +$23K ﹤0.01% 3017
2020
Q3
$18K Sell
64
-1
-2% -$288 ﹤0.01% 3082
2020
Q2
$16K Sell
65
-805
-93% -$162K ﹤0.01% 3043
2020
Q1
$126K Buy
870
+9
+1% +$1.49K ﹤0.01% 2641
2019
Q4
$147K Sell
861
-213
-20% -$39.5K ﹤0.01% 2687
2019
Q3
$191K Sell
1,074
-8,343
-89% -$1.8M ﹤0.01% 2642
2019
Q2
$2.45M Sell
9,417
-21,510
-70% -$5.71M ﹤0.01% 2275
2019
Q1
$8.83M Buy
30,927
+22,940
+287% +$7.62M ﹤0.01% 1903
2018
Q4
$2.6M Sell
7,987
-421,648
-98% -$146M ﹤0.01% 2222
2018
Q3
$193M Sell
429,635
-262,183
-38% -$103M 0.02% 676
2018
Q2
$283M Buy
691,818
+176,394
+34% +$63.9M 0.03% 519
2018
Q1
$150M Buy
515,424
+247,558
+92% +$62.7M 0.02% 808
2017
Q4
$50.2M Buy
267,866
+11,333
+4% +$2.12M 0.01% 1294
2017
Q3
$43.3M Buy
256,533
+28,977
+13% +$4.38M 0.01% 1368
2017
Q2
$32.6M Buy
+227,556
New +$30.6M ﹤0.01% 1482
2017
Q1
Sell
-176,303
Closed -$19.9M 2724
2016
Q4
$19.9M Sell
176,303
-200
-0.1% -$23.2K ﹤0.01% 1678
2016
Q3
$22.7M Buy
+176,503
New +$21.1M ﹤0.01% 1622
2016
Q2
Sell
-29,400
Closed -$2.79M 2717
2016
Q1
$2.79M Buy
+29,400
New +$2.48M ﹤0.01% 2303
2015
Q3
Sell
-83,300
Closed -$5.47M 2799
2015
Q2
$5.47M Buy
83,300
+12,800
+18% +$850K ﹤0.01% 2212
2015
Q1
$5.05M Sell
70,500
-19,796
-22% -$1.07M ﹤0.01% 2219
2014
Q4
$3.44M Buy
+90,296
New +$2.85M ﹤0.01% 2329

Other funds holding ABMD